glp-1 agonists long term side effects Adverse of Receptor What do you do when
Description
Industry Size (2026): USD 2.9 Bn Forecast (2036): USD 7.8 Bn CAGR (2026 to 2036): 11.7% GLP-1 Receptor Agonist Market Size, Market Forecast and Outlook By FMI The GLP-1 receptor agonist market is expected to expand from USD 2.9 billion in 2026 to USD 7.8 billion by 2036
In murine and human islets, GLP-1, via phospholipase C (PLC), leads to an activation of PKC, followed by membrane depolarization and stimulation of insulin secretion
For example, Wang et al
The ELAD Phase 2b trial of liraglutide, published in Nature Medicine, randomised 204 patients with mild to moderate disease to daily liraglutide or placebo for 52 weeks
Metabolic surgery and liver transplantation are therapeutic options for severe cases
CRS report R46679
